Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

2 Aug 2017 07:00

RNS Number : 8057M
Barr(A.G.) PLC
02 August 2017
 

IMMEDIATE RELEASE 2 August 2017

 

A.G. BARR p.l.c. 

 

("A.G. BARR")

 

Trading Update 

 

Revenue up 8% and Group on track to meet full year profit expectations

 

A.G. BARR, which produces and markets some of the UK's leading drink brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the 26 weeks ended 29 July 2017.

 

We are pleased to report a strong first half sales performance supported by the continued success of last year's new product launches. Revenue for the 26 weeks ended 29 July 2017 is expected to be £136m, an increase of c.8% on the same period in the prior year (2016: £125.6m).

 

This strong sales performance was delivered against a market backdrop that saw value increase by 3.5% and volume by 2.1% (Source: IRI UK soft drinks market data from 29 January to 18 June 2017). 

 

In the first half we increased our investment in support of our innovation and brand growth activity. This, combined with slightly later than anticipated phasing of price increases and generally higher operating costs, including the effect of weaker sterling on input costs, had a moderate impact on margins during the period.

 

We are making good progress with our sugar reduction programme and are confident that we will meet the portfolio target communicated in March 2017. We expect this programme to be completed by the end of the financial year (January 2018) as the reformulated products are phased in across the next six months.

 

Outlook

 

While the wider economic environment continues to be uncertain, we have a clear strategy and a strong commercial plan in place, and we remain confident that we will deliver a full year financial performance in line with the Board's expectations.

 

Roger White, Chief Executive Officer, commented:

 

"We have delivered a good first half with strong sales growth supported by our successful innovation programme, particularly IRN-BRU XTRA, which has now been launched in England and Wales, and Rubicon Spring, which is gaining distribution across multiple channels. We are well positioned to deliver against our expectations across the balance of the year."

 

 

For more information, please contact:

 

A.G. BARR 01236 852400

Roger White, Chief Executive

Stuart Lorimer, Finance Director

Instinctif Partners 020 7457 2020

Matthew Smallwood

Justine Warren

 

Next update: Interim Results - 26 September 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUPARUPMGAG
Date   Source Headline
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update
28th Mar 20237:00 amRNSFinal results for the year ended 29 January 2023
8th Mar 202310:57 amRNSDirector/PDMR Shareholding
8th Feb 202311:09 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
27th Jan 20232:39 pmRNSNotice of Trading Update
10th Jan 20232:01 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition of MOMA minority shareholding
14th Dec 20226:00 pmRNSContourGlobal
8th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition of Boost Drinks Holdings Limited
8th Nov 202210:41 amRNSDirector/PDMR Shareholding
1st Nov 20222:38 pmRNSDirector/PDMR Shareholding
1st Nov 20222:34 pmRNSDirector/PDMR Shareholding
1st Nov 20222:30 pmRNSDirector/PDMR Shareholding
25th Oct 20229:34 amRNSDirectorship
10th Oct 20221:44 pmRNSDirector/PDMR Shareholding
27th Sep 20227:05 amRNSUpdate statement on 2022 AGM Voting Results
27th Sep 20227:00 amRNSInterim Results
12th Sep 20223:18 pmRNSHolding(s) in Company
8th Sep 20222:08 pmRNSDirector/PDMR Shareholding
31st Aug 202210:29 amRNSNotice of Interim Results Date
8th Aug 20221:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.